| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a6002fbe630644625bdb02314726ae64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5fa06a7ea5e58003f38447c317bf611a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7c05b480c830c0e092b58164c259df4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7ccb011ca7093c4cd0d3a3c38852a656
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eead910f15d5f1f1dc8b54ea55084da3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2c7d26faa7022f3bdd6eed6bd55fcd6a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-163
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P21-005 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-20 |
| filingDate |
2011-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf6c697bfd34a51afbc83dbbb76223c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a985934bd1761df058f1ff72009a111f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0283ac729272da96f7b6ee684418a82c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13c8ebff396ef0eebd19fe41c116c639
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da7e0e89c70a67780065ca315c76768d |
| publicationDate |
2013-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8367408-B2 |
| titleOfInvention |
Fusion partner for production of monoclonal rabbit antibodies |
| abstract |
The invention provides a rabbit-derived immortal B-lymphocyte capable of fusion with a rabbit splenocyte to produce a hybrid cell that produces an antibody. The immortal B-lymphocyte does not detectably express endogenous immunoglobulin heavy chain and may contain, in certain embodiments, an altered immunoglobulin heavy chain-encoding gene. A hybridoma resulting from fusion between the subject immortal B-lymphocyte and a rabbit antibody-producing cell is provided, as is a method of using that hybridoma to produce an antibody. The subject invention finds use in a variety of different diagnostic, therapeutic and research applications. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3620793-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9388240-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015084994-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8986692-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014004566-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9328333-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015225477-A1 |
| priorityDate |
2005-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |